Reply to Allan-Blitz and Klausner
J Infect Dis
.
2017 Feb 1;215(3):491-492.
doi: 10.1093/infdis/jiw552.
Authors
Yonatan H Grad
1
2
,
Marc Lipsitch
1
3
Affiliations
1
Department of Immunology and Infectious Diseases, and.
2
Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
3
Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, and.
PMID:
28003355
PMCID:
PMC5873214
DOI:
10.1093/infdis/jiw552
No abstract available
Publication types
Comment
MeSH terms
Ciprofloxacin*
Codon
Neisseria gonorrhoeae*
Substances
Codon
Ciprofloxacin
Grants and funding
K08 AI104767/AI/NIAID NIH HHS/United States
U54 GM088558/GM/NIGMS NIH HHS/United States